A Review of CONSORT Guidelines about Comparison Groups with a Focused Discussion on Implications for Rehabilitation Clinical Trials

American Journal of Physical Medicine and Rehabilitation

Volumn 99, Issue 3, 2020, Pages 1-7

  Levack, William M M ^a   Engkasan, Julia P ^b   Heinemann, Allen W ^c   Negrini, Stefano ^d,e  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF MALAYA   (Malaysia)

^c NORTHWESTERN UNIVERSITY   (United States)

^d UNIVERSITY OF MILAN   (Italy)

^e IRCCS ISTITUTO ORTOPEDICO GALEAZZI   (Italy)

Author keywords

Control Groups; Randomized Controlled Trials; Rehabilitation; Reporting Standards

Indexed keywords

CLINICAL TRIAL (TOPIC); HUMAN; METHODOLOGY; PRACTICE GUIDELINE; REHABILITATION RESEARCH; RESEARCH;

CLINICAL TRIALS AS TOPIC; GUIDELINES AS TOPIC; HUMANS; REHABILITATION RESEARCH; RESEARCH DESIGN; RESEARCH REPORT;

EID: 85079825141     PISSN: 08949115     EISSN: 15377385     Source Type: Journal    
DOI: 10.1097/PHM.0000000000001368     Document Type: Article

References (49)

1. Levack WMM, Martin RA, Graham FP,: Compared to what? An analysis of the management of control groups in Cochrane reviews in neurorehabilitation. Eur J Phys Rehabil Med 2019; 55: 353-63
2. Hart T, Fann JR, Novack TA,: The dilemma of the control condition in experience-based cognitive and behavioural treatment research. Neuropsychol Rehabil 2008; 18: 1-21
3. Hart T,: Challenges in the evaluation of neuropsychological rehabilitation effects. In: Wilson BA, Winegardner J, van Heugten CM, Ownsworth T, (Eds), Neuropsychological Rehabilitation: The International Handbook. London: Francis & Taylor Group; 2017. p. 559-68
4. Roth EJ, Stenson KW, Powley S,: Expiratory muscle training in spinal cord injury: A randomized controlled trial. Arch Phys Med Rehabil 2010; 91: 857-61
5. Lohse KR, Pathania A, Wegman R,: On the reporting of experimental and control therapies in stroke rehabilitation trials: A systematic review. Arch Phys Med Rehabil 2018; 99: 1424-32
6. Brigham GS, Feaster DJ, Wakim PG,: Choosing a control group in effectiveness trials of behavioral drug abuse treatments. J Subst Abuse Treat 2009; 37: 388-97
7. Begg C, Cho M, Eastwood S,: Improving the quality of reporting of randomized controlled trials: The CONSORT statement. JAMA 1996; 276: 637-9
8. Schulz KF, Altman DG, Moher D,: CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. BMC Med 2010; 8: 18
9. Devereaux P, Manns BJ, Ghali WA,: The reporting of methodological factors in randomized controlled trials and the association with a journal policy to promote adherence to the Consolidated Standards of Reporting Trials (CONSORT) checklist. Control Clin Trials 2002; 23: 380-8
10. Turner L, Shamseer L, Altman DG,: Consolidated Standards of Reporting Trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals. Cochrane Database Syst Rev 2012
11. Levack WMM, Meyer T, Negrini S,: Cochrane Rehabilitation Methodology Committee: An international survey of priorities for future work. Eur J Phys Rehabil Med 2017; 53: 814-7
12. Levack WM, Malmivaara A, Meyer T,: Methodological problems in rehabilitation research. Report from a Cochrane Rehabilitation Methodology Meeting. Eur J Phys Rehabil Med 2019; 55: 319-21
13. Levack WMM, Rathore FA, Pollet J,: One in 11 Cochrane reviews are on rehabilitation interventions, according to pragmatic inclusion criteria developed by Cochrane rehabilitation. Arch Phys Med Rehabil 2019; 100: 1492-8
14. Campbell MK, Piaggio G, Elbourne DR,: Consort 2010 statement: Extension to cluster randomised trials. BMJ 2012; 345: E5661
15. Piaggio G, Elbourne DR, Altman DG,: Group C: Reporting of noninferiority and equivalence randomized trials: An extension of the CONSORT statement. JAMA 2006; 295: 1152-60
16. Ioannidis JP, Evans SJ, Gøtzsche PC,: Better reporting of harms in randomized trials: An extension of the CONSORT statement. Ann Intern Med 2004; 141: 781-8
17. Juszczak E, Altman DG, Hopewell S,: Reporting of multi-arm parallel-group randomized trials: Extension of the CONSORT 2010 Statement. JAMA 2019; 321: 1610-20
18. Vohra S, Shamseer L, Sampson M,: CONSORT extension for reporting N-of-1 trials (CENT) 2015 Statement. BMJ 2015; 350: H1738
19. Dwan K, Li T, Altman DG,: CONSORT 2010 Statement: Extension to randomised crossover trials. BMJ 2019; 366: L4378
20. Pandis N, Chung B, Scherer RW,: CONSORT 2010 statement: Extension checklist for reporting within person randomised trials. BMJ 2017; 357: J2835
21. Eldridge SM, Chan CL, Campbell MJ,: CONSORT 2010 Statement: Extension to randomised pilot and feasibility trials. BMJ 2016; 355: I5239
22. Thabane L, Hopewell S, Lancaster GA,: Methods and processes for development of a CONSORT extension for reporting pilot randomized controlled trials. Pilot Feasibility Stud 2016; 2: 25
23. Calvert M, Blazeby J, Altman DG,: Reporting of patient-reported outcomes in randomized trials: The CONSORT PRO extension. JAMA 2013; 309: 814-22
24. Gewandter JS, Eisenach JC, Gross RA,: Checklist for the preparation and review of pain clinical trial publications: A pain-specific supplement to CONSORT. Pain Rep 2019; 4: E621
25. Davidson KW, Goldstein M, Kaplan RM,: Evidence-based behavioral medicine: What is it and how do we achieve it? Ann Behav Med 2003; 26: 161-71
26. Nelson DL, Mathiowetz V,: Randomized controlled trials to investigate occupational therapy research questions. Am J Occup Ther 2004; 58: 24-34
27. Gagnier JJ, Boon H, Rochon P,: Recommendations for reporting randomized controlled trials of herbal interventions: Explanation and elaboration. J Clin Epidemiol 2006; 59: 1134-49
28. Gagnier J, Boon H, Rochon P,: Reporting random controlled trials of herbal medicines. Explore (NY) 2006; 2: 143-9
29. Cheng CW, Wu TX, Shang HC,: CONSORT extension for Chinese herbal medicine formulas 2017: Recommendations, explanation, and elaboration. Ann Intern Med 2017; 167: 112-21
30. Pandis N, Fleming PS, Hopewell S,: The CONSORT Statement: Application within and adaptations for orthodontic trials. Am J Orthod Dentofacial Orthop 2015; 147: 663-79
31. Dean ME, Coulter MK, Fisher P,: Reporting data on homeopathic treatments (RedHot): A supplement to CONSORT. J Altern Complement Med 2007; 13: 19-23
32. Hopewell S, Clarke M, Moher D,: CONSORT for reporting randomized controlled trials in journal and conference abstracts: Explanation and elaboration. PLoS Med 2008; 5: E20
33. Grant S, Mayo-Wilson E, Montgomery P,: CONSORT-SPI 2018 Explanation and Elaboration: Guidance for reporting social and psychological intervention trials. Trials 2018; 19: 406
34. Grant SP, Mayo-Wilson E, Melendez-Torres G,: Reporting quality of social and psychological intervention trials: A systematic review of reporting guidelines and trial publications. PloS One 2013; 8: E65442
35. Mayo-Wilson E, Grant S, Hopewell S,: Developing a reporting guideline for social and psychological intervention trials. Trials 2013; 14: 242
36. Montgomery P, Grant S, Mayo-Wilson E,: Reporting randomised trials of social and psychological interventions: The CONSORT-SPI 2018 extension. Trials 2018; 19: 407
37. Moher D, Hopewell S, Schulz KF,: CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trials. BMJ 2010; 340: C322
38. Zwarenstein M, Treweek S, Gagnier JJ,: Improving the reporting of pragmatic trials: An extension of the CONSORT statement. BMJ 2008; 337: A2390
39. Boutron I, Altman DG, Moher D,: CONSORT statement for randomized trials of nonpharmacologic treatments: A 2017 update and a CONSORT extension for nonpharmacologic trial abstracts. Ann Intern Med 2017; 167: 40-7
40. MacPherson H, Altman DG, Hammerschlag R,: Revised standards for reporting interventions in clinical trials of acupuncture (STRICTA): Extending the CONSORT statement. PLoS Med 2010; 7: E1000261
41. Hoffmann TC, Glasziou PP, Boutron I,: Better reporting of interventions: Template for intervention description and replication (TIDieR) checklist and guide. BMJ 2014; 348: G1687
42. Welch VA, Norheim OF, Jull J,: CONSORT-Equity 2017 extension and elaboration for better reporting of health equity in randomised trials. BMJ 2017; 359: J5085
43. Craig P, Dieppe P, Macintyre S,: Developing and evaluating complex interventions: The new Medical Research Council guidance. BMJ 2008; 337: 979-83
44. Paradis E, Sutkin G,: Beyond a good story: From Hawthorne effect to reactivity in health professions education research. Med Educ 2017; 51: 31-9
45. Levitt SD, List JA,: Was there really a Hawthorne effect at the Hawthorne plant? An analysis of the original illumination experiments. Am Econ J Appl Econ 2011; 3: 224-38
46. Bramel D, Friend R,: Hawthorne, the myth of the docile worker, and class bias in psychology. Am Psychol 1981; 36: 867-78
47. Adair JG, Sharpe D, Huynh C-L,: Hawthorne control procedures in educational experiments: A reconsideration of their use and effectiveness. Rev Educ Res 1989; 59: 215-28
48. McCambridge J, Witton J, Elbourne DR,: Systematic review of the Hawthorne effect: New concepts are needed to study research participation effects. J Clin Epidemiol 2014; 67: 267-77
49. Di Blasi Z, Harkness E, Ernst E,: Influence of context effects on health outcomes: A systematic review. Lancet 2001; 357: 757-62